These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 23932011)
1. The evolving role of stroke prediction schemes for patients with atrial fibrillation. Ha A; Healey JS Can J Cardiol; 2013 Oct; 29(10):1173-80. PubMed ID: 23932011 [TBL] [Abstract][Full Text] [Related]
2. Benefits and risks of oral anticoagulation for stroke prevention in nonvalvular atrial fibrillation. Garcia DA Thromb Res; 2012 Jan; 129(1):9-16. PubMed ID: 22018997 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study. Friberg L; Rosenqvist M; Lip GY Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443 [TBL] [Abstract][Full Text] [Related]
4. Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation. Fernandez MM; von Schéele B; Hogue S; Kwong WJ Am J Cardiovasc Drugs; 2013 Apr; 13(2):87-102. PubMed ID: 23572283 [TBL] [Abstract][Full Text] [Related]
5. A clinical prediction rule to identify patients with atrial fibrillation and a low risk for stroke while taking aspirin. van Walraven C; Hart RG; Wells GA; Petersen P; Koudstaal PJ; Gullov AL; Hellemons BS; Koefed BG; Laupacis A Arch Intern Med; 2003 Apr; 163(8):936-43. PubMed ID: 12719203 [TBL] [Abstract][Full Text] [Related]
6. Performance of the HEMORR(2)HAGES, ATRIA, and HAS-BLED bleeding risk-prediction scores in patients with atrial fibrillation undergoing anticoagulation: the AMADEUS (evaluating the use of SR34006 compared to warfarin or acenocoumarol in patients with atrial fibrillation) study. Apostolakis S; Lane DA; Guo Y; Buller H; Lip GY J Am Coll Cardiol; 2012 Aug; 60(9):861-7. PubMed ID: 22858389 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation. Jover E; Roldán V; Gallego P; Hernández-Romero D; Valdés M; Vicente V; Lip GY; Marín F Rev Esp Cardiol (Engl Ed); 2012 Jul; 65(7):627-33. PubMed ID: 22609214 [TBL] [Abstract][Full Text] [Related]
8. Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded. Man-Son-Hing M; Laupacis A Arch Intern Med; 2003 Jul; 163(13):1580-6. PubMed ID: 12860581 [TBL] [Abstract][Full Text] [Related]
9. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies. Garwood CL; Hwang JM; Moser LR Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182 [TBL] [Abstract][Full Text] [Related]
10. An overview of stroke and the impact of atrial fibrillation. Cannon CP Am J Manag Care; 2010 Nov; 16(10 Suppl):S273-7. PubMed ID: 21517641 [TBL] [Abstract][Full Text] [Related]
11. [Atrial fibrillation and stroke]. Aamodt AH; Sandset PM; Atar D; Tveit A; Russell D Tidsskr Nor Laegeforen; 2013 Aug; 133(14):1453-7. PubMed ID: 23929293 [TBL] [Abstract][Full Text] [Related]
12. [Stroke risk stratification in atrial fibrillation: oral anticoagulant therapy and bleeding risk in the elderly]. Poli D; Grifoni E Recenti Prog Med; 2011 Jan; 102(1):23-7. PubMed ID: 21516668 [TBL] [Abstract][Full Text] [Related]
13. Implications of the CHA(2)DS(2)-VASc and HAS-BLED Scores for thromboprophylaxis in atrial fibrillation. Lip GY Am J Med; 2011 Feb; 124(2):111-4. PubMed ID: 20887966 [TBL] [Abstract][Full Text] [Related]
14. Anticoagulant prophylaxis against stroke in atrial fibrillation: effectiveness in actual practice. Caro JJ; Flegel KM; Orejuela ME; Kelley HE; Speckman JL; Migliaccio-Walle K CMAJ; 1999 Sep; 161(5):493-7. PubMed ID: 10497604 [TBL] [Abstract][Full Text] [Related]
15. Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices. Savelieva I; Bajpai A; Camm AJ Ann Med; 2007; 39(5):371-91. PubMed ID: 17701479 [TBL] [Abstract][Full Text] [Related]
16. Differences among clinical classification schemes for predicting stroke in atrial fibrillation: implications for therapy in daily practice. Laguna P; Martín A; Del Arco C; Millán I; Gargantilla P; Acad Emerg Med; 2005 Sep; 12(9):828-34. PubMed ID: 16141016 [TBL] [Abstract][Full Text] [Related]
17. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke Risk in Atrial Fibrillation Working Group Stroke; 2008 Jun; 39(6):1901-10. PubMed ID: 18420954 [TBL] [Abstract][Full Text] [Related]
18. Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: design of the MUSICA-2 randomized trial. Sambola A; Montoro JB; Del Blanco BG; Llavero N; Barrabés JA; Alfonso F; Bueno H; Cequier A; Serra A; Zueco J; Sabaté M; Rodríguez-Leor O; García-Dorado D Am Heart J; 2013 Oct; 166(4):669-75. PubMed ID: 24093846 [TBL] [Abstract][Full Text] [Related]
19. Multicenter randomized study of anticoagulation guided by remote rhythm monitoring in patients with implantable cardioverter-defibrillator and CRT-D devices: Rationale, design, and clinical characteristics of the initially enrolled cohort The IMPACT study. Ip J; Waldo AL; Lip GY; Rothwell PM; Martin DT; Bersohn MM; Choucair WK; Akar JG; Wathen MS; Rohani P; Halperin JL; Am Heart J; 2009 Sep; 158(3):364-370.e1. PubMed ID: 19699858 [TBL] [Abstract][Full Text] [Related]